Minerva Neurosciences, Inc. (NERV)
NASDAQ: NERV · Real-Time Price · USD
5.87
+0.17 (2.98%)
At close: Apr 14, 2026, 4:00 PM EDT
5.98
+0.11 (1.87%)
After-hours: Apr 14, 2026, 4:32 PM EDT
Minerva Neurosciences Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Minerva Neurosciences stock has a target of 7.00, which predicts a 19.25% increase from the current stock price of 5.87.
Price Target: $7.00 (+19.25%)
Analyst Consensus: Hold
* Price targets were last updated on Mar 12, 2026.
Analyst Ratings
According to 1 stock analyst, the rating for Minerva Neurosciences is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $4 → $7 | Hold | Maintains | $4 → $7 | +19.25% | Mar 12, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $5 → $4 | Hold | Maintains | $5 → $4 | -31.86% | Nov 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $5 | Hold | Reiterates | $5 | -14.82% | Feb 26, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $5 | Hold | Reiterates | $5 | -14.82% | Nov 6, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $7 → $5 | Hold | Maintains | $7 → $5 | -14.82% | Aug 7, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.77
from -34.67
EPS Next Year
-0.58
from -0.77
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | n/a | n/a | |||
| Avg | n/a | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.67 | -0.50 | |||
| Avg | -0.77 | -0.58 | |||
| Low | -0.85 | -0.65 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.